U.S. Markets closed

Paradigm Medical Industries Inc. (PDMI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.0000%)
At close: 3:08PM EDT
People also watch
ASFXHTDSLLBOIDOIWLSI

Paradigm Medical Industries Inc.

4273 South 590 West
Salt Lake City, UT 84123
United States
801-977-8970

Sector
Industry
Full Time Employees5

Key Executives

NameTitlePayExercisedAge
Mr. Charles S. PritchardVP of Sales and MarketingN/AN/AN/A
Mr. Rudolph SchneidManaging Director of European OperationsN/AN/AN/A
Ms. Deborah PetricDirector of Regulatory Affairs & Quality AssuranceN/AN/AN/A
Mr. Jose AngeloInformation Technology Mang.N/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.

Corporate Governance

Paradigm Medical Industries Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.